Life360, Inc. — Director's Dealing 2021

Jun 14, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Christopher (Chris) Hulls
Date of last notice	7 May 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	8 June 2021 (PDT)
No. of securities held prior to change	 8,659,656 CHESS Depositary Interests (CDIs)  10,872 Shares of Common Stock (Shares)(equivalent to 32,616 CDIs)  1,808,383 Options over Shares (Options)  82,971 Restricted Stock Units (RSUs)  29,960 Shares (equivalent to 89,880 CDIs)held byICCA Labs,LLC1
Class	Options & RSUs
Number acquired	12,864 Shares

1 Chris Hulls is a member of ICCA Labs, LLC, an entity that holds Life360 shares. The number of shares attributable to Chris Hulls by reason of his membership interest in ICCA Labs, LLC is 29,960.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	19,609 RSUs (having vested)
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	Executive RSUs are granted for no consideration. No consideration is payable by an executive upon the vesting and settlement of RSUs.
No. of securities held after change	 8,659,656 CDIs  23,736 Shares (equivalent to 71,208 CDIs)  1,808,383 Options  63,362 RSUs  29,960 Shares (equivalent to 89,880 CDIs) held by ICCA Labs, LLC
Nature of change Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back	Issue of Shares following the vesting and settlement of RSUs.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3